Vorinostat Completed Phase 1 Trials for Leukemia, Myelocytic, Acute Myelodysplastic Syndromes / Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00479232Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)